ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.20
0.02%
US Tech 100
20,811.20
-1.10%
S&P 500
5,983.25
-0.50%
US Dollar vs CAD
1.42489
-0.20%
Bitcoin
91,941.67
0.55%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Armata Pharmaceuticals Inc (ARMP)

  7. Armata Pharmaceuticals Inc (ARMP) News

ARMP

Armata Pharmaceuticals (ARMP)

Armata Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ARMP
DateTimeSourceHeadlineSymbolCompany
02/07/20253:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
02/07/20253:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
12/19/20246:38AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
12/04/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
11/15/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
11/14/20243:17PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
11/13/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
11/13/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
11/12/20246:07AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
10/03/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
10/03/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
09/26/20243:33PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
08/26/20246:50AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
08/19/20243:15PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ARMPArmata Pharmaceuticals Inc
08/15/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
08/13/20243:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
08/13/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
07/25/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
06/14/20243:09PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
05/07/20243:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ARMPArmata Pharmaceuticals Inc
05/07/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
03/04/20244:35PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ARMPArmata Pharmaceuticals Inc
03/04/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:ARMPArmata Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:ARMP

Your Recent History

USOTC
AZRH
Azure (PK)
USOTC
CYDY
CytoDyn (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
RDAR
Raadr (PK)
USOTC
ASII
Accredited Solutions (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
AABB
Asia Broadband (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
NUGN
NuGene (PK)
COIN
XRPUSD
Ripple
NASDAQ
NB
NioCorp Developments
USOTC
VDRM
ViaDerma (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
FDCT
FDCTech (PK)
NASDAQ
COOP
Mr Cooper
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads